Skip to main content
Top
Published in: Familial Cancer 2/2014

01-06-2014 | Original Article

Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing

Authors: Ian Teng, Allan Spigelman

Published in: Familial Cancer | Issue 2/2014

Login to get access

Abstract

Genetic testing for susceptibility for common cancers is widely available. Thus, doctors have a role in identifying and referring patients who would benefit from a consultation with a specialist in genetics. This study aims to assess doctors’ referral rates, knowledge and attitudes towards cancer genetic testing, broken down by specialty (gastrointestinal, breast/ovarian, other specialties and General Practitioners-GPs). A 4-page questionnaire was mailed out to the GPs of all patients seen in 2012 in the Hereditary Cancer Clinic of St. Vincent’s Hospital Sydney (n = 128) and all the specialists in St. Vincent’s Hospital Sydney that might refer to the HCC (n = 33). 50 questionnaires were returned (31 %). Most doctors had referred a patient for cancer genetic testing (90 %). The average proportion of patients referred was 1 in 68.5 patients with breast/ovarian specialists referring the most, followed by gastrointestinal specialists and GPs. There was suboptimal knowledge of cancer genetic testing amongst doctors. Breast/ovarian specialists were most knowledgeable, followed by gastrointestinal specialists, other specialists and GPs. There were indications of inappropriate referral amongst doctors. Most (77.6 %) doctors were willing to receive further information on cancer genetics. Nearly all (94 %) doctors believe that it is their duty to inform an individual at high risk for hereditary cancer that cancer genetic counselling and testing is available. The majority of doctors have positive attitudes towards cancer genetic testing. Defective knowledge scores, however, indicate that doctors need further training or tools to enable them to refer patients appropriately for cancer genetic testing.
Appendix
Available only for authorised users
Literature
1.
go back to reference Freedman AN, Wideroff L, Olson L, Davis W, Klabunde C, Srinath KP, Reeve BB, Croyle RT, Ballard-Barbash R (2003) US physicians’ attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A 120A(1):63–71PubMedCrossRef Freedman AN, Wideroff L, Olson L, Davis W, Klabunde C, Srinath KP, Reeve BB, Croyle RT, Ballard-Barbash R (2003) US physicians’ attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A 120A(1):63–71PubMedCrossRef
2.
go back to reference Escher M, Sappino AP (2000) Primary care physicians’ knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 11(9):1131–1135PubMedCrossRef Escher M, Sappino AP (2000) Primary care physicians’ knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 11(9):1131–1135PubMedCrossRef
3.
go back to reference Pichert G, Dietrich D, Moosmann P, Zwahlen M, Stahel RA, Sappino AP (2003) Swiss primary care physicians’ knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Fam Cancer 2(3–4):153–158PubMed Pichert G, Dietrich D, Moosmann P, Zwahlen M, Stahel RA, Sappino AP (2003) Swiss primary care physicians’ knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Fam Cancer 2(3–4):153–158PubMed
4.
go back to reference Van Riel E, Warlam-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG (2010) BRCA testing of breast cancer patients: medical specialists’ referral patterns, knowledge and attitudes to genetic testing. Eur J Cancer Care (Engl) 19 (3):369–376. doi:10.1111/j.1365-2354.2008.01065.x Van Riel E, Warlam-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG (2010) BRCA testing of breast cancer patients: medical specialists’ referral patterns, knowledge and attitudes to genetic testing. Eur J Cancer Care (Engl) 19 (3):369–376. doi:10.​1111/​j.​1365-2354.​2008.​01065.​x
5.
go back to reference Carroll JC, Brown JB, Blaine S, Glendon G, Pugh P, Medved W (2003) Genetic susceptibility to cancer. Family physicians’ experience. Can Fam Physician 49:45–52PubMedCentralPubMed Carroll JC, Brown JB, Blaine S, Glendon G, Pugh P, Medved W (2003) Genetic susceptibility to cancer. Family physicians’ experience. Can Fam Physician 49:45–52PubMedCentralPubMed
6.
go back to reference Lucassen AM, Houlston RS (2000) Clinical geneticists’ attitudes and practice towards testing for breast cancer susceptibility genes. J Med Genet 37(2):157–160PubMedCentralPubMedCrossRef Lucassen AM, Houlston RS (2000) Clinical geneticists’ attitudes and practice towards testing for breast cancer susceptibility genes. J Med Genet 37(2):157–160PubMedCentralPubMedCrossRef
7.
go back to reference Trivers KF, Baldwin LM, Miller JW, Matthews B, Andrilla CH, Lishner DM, Goff BA (2011) Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study. Cancer 117 (23):5334–5343. doi:10.1002/cncr.26166 Trivers KF, Baldwin LM, Miller JW, Matthews B, Andrilla CH, Lishner DM, Goff BA (2011) Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study. Cancer 117 (23):5334–5343. doi:10.​1002/​cncr.​26166
8.
go back to reference McCarthy AM, Bristol M, Fredricks T, Wilkins L, Roelfsema I, Liao K, Shea JA, Groeneveld P, Domchek SM, Armstrong K (2013) Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study. Cancer. doi:10.1002/cncr.28268 McCarthy AM, Bristol M, Fredricks T, Wilkins L, Roelfsema I, Liao K, Shea JA, Groeneveld P, Domchek SM, Armstrong K (2013) Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study. Cancer. doi:10.​1002/​cncr.​28268
10.
go back to reference National Cancer Institute (2009) BRCA1 and BRCA2: cancer risk and genetic testing. National Cancer Institute National Cancer Institute (2009) BRCA1 and BRCA2: cancer risk and genetic testing. National Cancer Institute
11.
go back to reference Culver JO, Hull JL, Dunne DF, Burke W (2001) Oncologists’ opinions on genetic testing for breast and ovarian cancer. Genet Med 3(2):120–125PubMedCrossRef Culver JO, Hull JL, Dunne DF, Burke W (2001) Oncologists’ opinions on genetic testing for breast and ovarian cancer. Genet Med 3(2):120–125PubMedCrossRef
12.
go back to reference Acheson LS, Stange KC, Zyzanski S (2005) Clinical genetics issues encountered by family physicians. Genet Med 7(7):501–508PubMedCrossRef Acheson LS, Stange KC, Zyzanski S (2005) Clinical genetics issues encountered by family physicians. Genet Med 7(7):501–508PubMedCrossRef
13.
go back to reference Wideroff L, Freedman AN, Olson L, Klabunde CN, Davis W, Srinath KP, Croyle RT, Ballard-Barbash R (2003) Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev 12(4):295–303PubMed Wideroff L, Freedman AN, Olson L, Klabunde CN, Davis W, Srinath KP, Croyle RT, Ballard-Barbash R (2003) Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev 12(4):295–303PubMed
14.
go back to reference Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN (2013) Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 42(10):749CrossRef Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN (2013) Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 42(10):749CrossRef
15.
go back to reference Cremers R, van Asperen C, Kil P, Vasen H, Wiersma T, van Oort I, Kiemeney L (2012) Urologists’ and GPs’ knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands. Fam Cancer 11 (2):195–200. doi:10.1007/s10689-011-9500-8 Cremers R, van Asperen C, Kil P, Vasen H, Wiersma T, van Oort I, Kiemeney L (2012) Urologists’ and GPs’ knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands. Fam Cancer 11 (2):195–200. doi:10.​1007/​s10689-011-9500-8
16.
go back to reference Baars MJ, Henneman L, Ten Kate LP (2005) Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genet Med 7(9):605–610PubMedCrossRef Baars MJ, Henneman L, Ten Kate LP (2005) Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genet Med 7(9):605–610PubMedCrossRef
17.
go back to reference Doksum T, Bernhardt BA, Holtzman NA (2003) Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? Genet Med 5(2):99–105PubMedCrossRef Doksum T, Bernhardt BA, Holtzman NA (2003) Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? Genet Med 5(2):99–105PubMedCrossRef
18.
go back to reference Morgan S, McLeod D, Kidd A, Langford B (2004) Genetic testing in New Zealand: the role of the general practitioner. N Z Med J 117(1206):U1178PubMed Morgan S, McLeod D, Kidd A, Langford B (2004) Genetic testing in New Zealand: the role of the general practitioner. N Z Med J 117(1206):U1178PubMed
19.
go back to reference McCann S, MacAuley D, Barnett Y, Bunting B, Bradley A, Jeffers L, Morrison PJ (2007) Cancer genetics: consultants’ perceptions of their roles, confidence and satisfaction with knowledge. J Eval Clin Pract 13(2):276–286PubMedCrossRef McCann S, MacAuley D, Barnett Y, Bunting B, Bradley A, Jeffers L, Morrison PJ (2007) Cancer genetics: consultants’ perceptions of their roles, confidence and satisfaction with knowledge. J Eval Clin Pract 13(2):276–286PubMedCrossRef
20.
go back to reference Mehnert A, Bergelt C, Koch U (2003) Knowledge and attitudes of gynecologists regarding genetic counseling for hereditary breast and ovarian cancer. Patient Educ Couns 49(2):183–188PubMedCrossRef Mehnert A, Bergelt C, Koch U (2003) Knowledge and attitudes of gynecologists regarding genetic counseling for hereditary breast and ovarian cancer. Patient Educ Couns 49(2):183–188PubMedCrossRef
Metadata
Title
Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing
Authors
Ian Teng
Allan Spigelman
Publication date
01-06-2014
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 2/2014
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-013-9695-y

Other articles of this Issue 2/2014

Familial Cancer 2/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine